Transfer of chromosome 18 into human head and neck squamous carcinoma cells: Evidence for tumor suppression by Smad4/DPC4

Cell Growth and Differentiation

Volumn 8, Issue 4, 1997, Pages 407-415

  Reiss, Michael ^a   Santoro, Vincenzo ^a,b   De Jonge, Rosalein R ^a   Vellucci, Vincent F ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER INHIBITION; CARCINOGENICITY; CARCINOMA CELL; CHROMOSOME 18Q; CONTROLLED STUDY; FEMALE; GENE DELETION; GENE TRANSFER; HEAD AND NECK CARCINOMA; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; TUMOR SUPPRESSOR GENE;

ANIMALS; CARCINOMA, SQUAMOUS CELL; CHROMOSOME BANDING; CHROMOSOMES, HUMAN, PAIR 18; DNA-BINDING PROTEINS; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENES, TUMOR SUPPRESSOR; HEAD AND NECK NEOPLASMS; HUMANS; MICE; MICE, NUDE; PHENOTYPE; SMAD4 PROTEIN; TRANS-ACTIVATORS;

ANIMALIA; MUS MUSCULUS;

EID: 0030991288     PISSN: 10449523     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Wingo, P. A., Tong, T., and Bolden, S. Cancer statistics, 1995. CA Cancer J. Clin., 45: 8-30, 1995.
2. Reiss, M., Muñoz-Antonia, T., Cowan, J. M., Wilkins, P. C., Zhou, Z-L., and Vellucci, V. F. Resistance of human squamous carcinoma cells to the anti-proliferative effect of transforming growth factor-β is a recessive phenotype. Proc. Natl. Acad. Sci. USA, 90: 6280-6284, 1993.
3. Knudson, A. G., Jr. Heredity, cancer, oncogenes, and antioncogenes. Cancer Res., 45: 1437-1443, 1985.
4. Fearon, E. R., Cho, K. R., Nigro, Kern, S. E., Simons, J. W., Ruppert, J. M., Hamilton, S. R., Preisinger, A. C., Thomas, G., Kinzler, K. W., and Vogelstein, B. Identification of a chromosome 18q gene which is altered in colorectal cancers. Science (Washington DC), 247: 49-56, 1990.
5. Hahn, S. A., Hoque, A. T. M. S., Moskaluk, C. A., da Costa, L. T., Schutte, M., Rozenblum, E., Seymour, A. B., Weinstein, C. L., Yeo, C. J., Hruban, R. H., and Kern, S. E. Homozygous deletion map at 18q21.1 in pancreatic cancer. Cancer Res., 56: 490-494, 1996.
6. Tsuchiya, E., Nakamura, Y., Weng, S-Y., Nakagawa, K., Tsuchiya, S., Sugano, H., and Kitagawa, T. Allelotype of non-small cell lung carcinoma: comparison between loss of heterozygosity in squamous cell carcinoma and adenocarcinoma. Cancer Res., 52: 2478-2481, 1992.
7. Huang, Y., Boynton, R. F., Blount, P. L., Silverstein, R. J., Yin, J., Tong, Y., McDaniel, T. K., Newkirk, C., Resau, J. H., Sridhara, R., Reid, B. J., and Meltzer, S. J. Loss of heterozygosity involves multiple tumor suppressor genes in human esophageal cancers. Cancer Res., 52: 6525-6530, 1992.
8. Miyake, S., Nagai, K., Yoshino, K., Oto, M., Endo, M., and Yuasa, Y. Point mutations and allelic deletion of tumor suppressor gene DCC in human esophageal squamous cell carcinomas and their relation to metastasis. Cancer Res., 54: 3007-3010, 1994.
9. Shibagaki, I., Shimada, Y., Wagata, T., Ikenaga, M., Imamura, M., and Ishizaki, K. Allelotype analysis of esophageal squamous cell carcinoma. Cancer Res., 54: 2996-3000, 1994.
10. Ah-see, K. W., Cooke, T. G., Pickford, I. R., Soutar, D., and Balmain, A. An allelotype of squamous carcinoma of the head and neck using microsatellite markers. Cancer Res., 54: 1617-1621, 1994.
11. Nawroz, H., van der Riet, P., Hruban, R. H., Koch, W., Ruppert, J. M., and Sidransky, D. Allelotype of head and neck squamous cell carcinoma. Cancer Res., 54: 1152-1155, 1994.
12. Cowan, J. M., Beckett, M. A., Ahmed-Swan, S., and Weichselbaum, R. R. Cytogenetic evidence of the multistep origin of head and neck squamous cell carcinomas. J. Natl. Cancer Inst., 84: 793-797, 1992.
13. Jin, Y., Mertens, F., Mandahl, N., Heim, S., Olegård, C., Wennerberg, J., Blörklund, A., and Mitelman, F. Chromosome abnormalities in eighty-three head and neck squamous cell carcinomas: influence of culture conditions on karyotypic pattern. Cancer Res., 53: 2140-2146, 1993.
14. Van Dyke, D. L., Worsham, M. J., Benninger, M. S., Krause, C. J., Baker, S. R., Wolf, G. T., Drumheller, T., Tilley, B. C., and Carey, T. E. Recurrent cytogenetic abnormalities in squamous cell carcinomas of the head and neck region. Genes Chromosomes Cancer, 9: 192-206, 1994.
15. Rowley, H., Jones, A. S., and Field, J. K. Chromosome 18, a possible site for a tumour suppressor gene deletion in squamous cell carcinoma of the head and neck. Clin. Otolaryngol., 20: 266-271, 1995.
16. Schutte, M., Hruban, R. H., Hedrick, L., Cho, K. R., Nadasdy, G. M., Weinstein, C. L., Bova, G. S., Isaacs, W. B., Cairns, P., Nawroz, H., Sidransky, D., Casero, R. A., Meltzer, P. S., Hahn, S. A., and Kern, S. E. DPC4 gene in various tumor types. Cancer Res., 56: 2527-2530, 1996.
17. Jen, J., Kim, H., Piantadosi, S., Liu, Z. F., Levitt, R. C., Sistonen, P., Kinzler, K. W., Vogelstein, B., and Hamilton, S. R. Allelic loss of chromosome 18q and prognosis in colorectal cancer. N. Engl. J. Med., 331: 213-221, 1994.
18. Kelker, W., Van Dyke, D. L., Worsham, M. J., Christopherson, P. L., James, C. D., Conlon, M. R., and Carey, T. E. Loss of 18q and homozygosity for the DCC locus: possible markers for clinically aggressive squamous cell carcinoma. Anticancer Res., 16: 2365-2372, 1996.
19. Eppert, K., Scherer, S. W., Ozcelik, H., Pirone, R., Hoodless, P., Kim, H., Tsui, L-C., Bapat, B., Gallinger, S., Andrulis, I. L., Thomsen, G. H., Wrana, J. L., and Attisano, L. MADR2 maps to 18q21 and encodes a TGFβ-regulated MAD-related protein that is functionally mutated in colorectal carcinoma. Cell, 86: 543-552, 1996.
20. Riggins, G. J., Thiagalingam, S., Rozenblum, E., Weinstein, C. L., Kern, S. E., Hamilton, S. R., Willson, J. K. V., Markowitz, S. D., Kinzler, K. W., and Vogelstein, B. Mad-related genes in the human. Nat. Gen., 13: 347-349, 1996.
21. Thiagalingam, S., Lengauer, C., Leach, F. S., Schutte, M., Hahn, S. A., Overhauser, J., Willson, J. V. K., Markowitz, S., Hamilton, S. R., Kern, S. E., Kinzler, K. W., and Vogelstein, B. Evaluation of candidate tumour suppressor genes on chromosome 18 in colorectal cancers. Nat. Gen., 13: 343-346, 1996.
22. Cho, K. R., Oliner, J. D., Simons, J. W., Hedrick, L., Fearon, E. R., Preisinger, A. C., Hedge, P., Silverman, G. A., and Vogelstein, B. The DCC gene: structural analysis and mutations in colorectal carcinomas. Genomics, 19: 525-531, 1994.
23. Keino-Masu, K., Masu, M., Hinck, L., Leonardo, E. D., Chan, S. S-Y., Culotti, J. G., and Tessier-Lavigne, M. Deleted in Colorectal Cancer (DCC) encodes a netrin receptor. Cell, 87: 175-185, 1996.
24. Hedrick, L., Cho, K. R., Fearon, E. R., Wu, T-C., Kinzler, K. W., and Vogelstein, B. The DCC gene product in cellular differentiation and colorectal tumorigenesis. Genes Dev., 8: 1174-1183, 1994.
25. Hahn, S. A., Schutte, M., Hoque, A. T. M. S., Moskaluk, C. A., da Costa, L. T., Rozenblum, E., Weinstein, C. L., Fischer, A., Yeo, C. J., Hruban, R. H., and Kern, S. E. DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1. Science (Washington DC), 277: 350-353, 1996.
26. Massagué, J. TGFβ signaling: receptors, transducers, and Mad proteins. Cell, 85: 947-950, 1996.
27. Derynck, R., Gelbart, W. M., Harland, R. M., Heldin, C-H., Kern, S. E., Massagué, J., Melton, D. A., Mlodzik, M., Padgett, R. W., Roberts, A. B., Smith, J., Thomsen, G. H., Vogelstein, B., and Wang, X-F. Nomenclature: vertebrate mediators of TGFβ family signals. Cell, 87: 173, 1996.
28. Fynan, T. M., and Reiss, M. Resistance to inhibition of cell growth by transforming growth factor-β and its role in oncogenesis. Crit. Rev. Oncog., 4: 493-540, 1993.
29. Kim, S. K., Fan, Y., Papadimitrikopoulou, V., Clayman, G., Hittelman, W. N., Hong, W. K., Lotan, R., and Mao, L. DPC4, a candidate tumor suppressor gene, is altered infrequently in head and neck squamous cell carcinoma. Cancer Res., 56: 2519-2521, 1996.
30. Nagatake, M., Takagi, Y., Osada, H., Uchida, O., Mitsudomi, T., Saji, S., Shimokata, K., Takahashi, T., and Takahashi, T. Somatic in vivo alterations of the DPC4 gene at 18q21.1 in human lung cancers. Cancer Res., 56: 2718-2720, 1996.
31. Goyette, M. C., Cho, K., Fashing, C. L., Levy, D. B., Kinzler, K. W., Paraskeva, C., Vogelstein, B., and Stanbridge, E. J. Progression of colorectal cancer is associated with multiple tumor suppressor gene defects but inhibition of tumorigenicity is accomplished by correction of any single defect via chromosome transfer. Mol. Cell. Biol., 12: 1387-1395, 1992.
32. Geurts van Kessel, A., Straub, R. E., Silverman, G. A., Gerken, S., and Overhauser, J. Report of the second international workshop on human chromosome 18 mapping. Cytogenet. Cell Genet., 65: 142-158, 1994.
33. Murray, J. C., Buetow, K. H., Weber, J. L., Ludwigsen, S., Scherpbier-Heddema, T., Manion, F., Quillen, J., Sheffield, V. C., Sunden, S., Duyk, G. M., Weissenbach, J., Gyapay, G., Dib, C., Morrissette, J., Lathrop, G. M., Vignal, A., White, R., Matsunami, N., Gerken, S., Melis, R., Albertsen, H., Plaetke, R., Odelberg, S., Ward, D., Dausset, J., Cohen, D., and Cann, H. A comprehensive human linkage map with centimorgan density. Science (Washington DC), 265: 2049-2054, 1994.
34. Risinger, J. I., and Boyd, J. Dinucleotide repeat polymorphisms in the human DCC gene at chromosome 18q21. Hum. Mol. Genet., 1: 657, 1992.
35. Reale, M. A., Hu, G., Zafar, A. I., Getzenberg, R. H., Levine, S. M., and Fearon, E. R. Expression and alternative splicing of the deleted in colon cancer (DCC) gene in normal and malignant tissues. Cancer Res., 54: 4493-4501, 1994.
36. Zhang, Y., Feng, X-H., Wu, R-Y., and Derynck, R. Receptor-associated Mad homologues synergize as effectors of the TGFβ response. Nature (Lond.), 383: 168-172, 1996.
37. Tanaka, K., Oshimura, M., Kikuchi, R., Seki, M., Hayashi, T., and Miyaki, M. Suppression of tumorigenicity in human colon carcinoma cells by introduction of normal chromosome 5 or 18. Nature (Lond.), 349: 340-342, 1991.
38. Anderson, M. J., and Stanbridge, E. J. Tumor suppressor genes studied by cell hybridization and chromosome transfer. FASEB J., 7: 826-833, 1993.
39. Merlo, A., Gabrielson, E., Mabry, M., Vollmer, R., Baylin, S. B., and Sidransky, D. Homozygous deletion on chromosome 9p and loss of heterozygosity on 9q, 6p, and 6q in primary human small cell lung cancer. Cancer Res., 54: 2322-2326, 1994.
40. Zou, Z., Anisowicz, A., Hendrix, M. J. C., Thor, A., Neveu, M., Sheng, S., Rafidi, K., Seftor, E., and Sager, R. Maspin, a serpin with tumor-suppressing activity in human mammary epithelial cells. Science (Washington DC), 263: 526-529, 1994.
41. Liu, F., Hata, A., Baker, J. C., Doody, J., Carcamo, J., Harland, R. M., and Massagué, J. A human Mad protein acting as a BMP-regulated transcriptional activator. Nature (Lond.), 381: 620-623, 1996.
42. Macias-Silva, M., Abdollah, S., Hoodless, P. A., Pirone, R., Attisano, L., and Wrana, J. L. MADR2 is a substrate of the TGFβ receptor and its phosphorylation is required for nuclear accumulation and signaling. Cell, 87: 1215-1224, 1996.
43. Pirisi, L., Yasumoto, S., Feller, M., Doniger, J., and DiPaolo, J. A. Transformation of human fibroblasts and keratinocytes with human papillomavirus type 16 DNA. J. Virol., 61: 1061-1066, 1987.
44. Chen, T. R. In situ detection of Mycoplasma contamination in cell cultures by fluorescent Hoechst 33258 stain. Exp. Cell Res., 104: 255-262, 1977.
45. Ning, Y., Lovell, M., Taylor, L., and Pereira-Smith, O. M. Isolation of monochromosomal hybrids following fusion of human diploid fibroblast-derived microcells with mouse A9 cells. Cytogen. Cell Genet., 60: 79-80, 1992.
46. Reiss, M., Vellucci, V. F., and Zhou, Z-L. Mutant p53 tumor suppressor gene causes resistance to transforming growth factor-β1 in murine keratinocytes. Cancer Res., 53: 899-904, 1993.
47. Litt, M., Hauge, X., and Sharma, V. Shadow bands seen when typing polymorphic dinucleotide repeats: some causes and cures. Biotechniques, 15: 280-284, 1993.
48. Reiss, M., and Dibble, C. L. Reinitiation of DNA synthesis in quiescent mouse keratinocytes: regulation by polypeptide hormones, cholera toxin, dexamethasone, and retinoic acid. In Vitro, 24: 537-544, 1988.